Atlas Trials

Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease

Clinical trial NCT04328922 · UNKNOWN

Trial details

NCT number
NCT04328922
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Crohn DiseaseMicrobial Substitution
Start date
2018-07-03
Primary completion
2022-04-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.